Skip to Content

Influenza virus vaccine, h5n1 Disease Interactions

There are 3 disease interactions with influenza virus vaccine, h5n1:

Major

Influenza virus vaccine H5N1 (Includes influenza virus vaccine, h5n1) ↔ Guillain-Barre Syndrome (GBS)

Severe Potential Hazard, Moderate plausibility. Applies to: Guillain-Barre Syndrome

Careful consideration of the potential risks and benefits should be given before deciding to give the influenza virus vaccine H5N1 to any patient who developed GBS within 6 weeks of receipt of a prior influenza vaccine.

Moderate

Influenza virus vaccine H5N1 (Includes influenza virus vaccine, h5n1) ↔ hemophilia

Moderate Potential Hazard, Moderate plausibility. Applies to: Bleeding Associated with Coagulation Defect

As with other intramuscular injections, this vaccine should be given with caution in individuals with bleeding disorders, such as hemophilia or on anticoagulation therapy, to avoid the risk of hematoma following the injection.

Moderate

Influenza virus vaccine H5N1 (Includes influenza virus vaccine, h5n1) ↔ immunodeficiency

Moderate Potential Hazard, Moderate plausibility. Applies to: Immunodeficiency

If Influenza Virus Vaccine, H5N1, is administered to immunocompromised patients, including individuals receiving immunosuppressive therapy, the expected immune response may not be obtained.

Influenza virus vaccine, h5n1 drug interactions

There are 202 drug interactions with influenza virus vaccine, h5n1

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide